Bivalent COVID Vaccines Perform Worse Against Variant Now Dominant in United States: Studies
• arclein"Following bivalent mRNA boosting, responses to XBB.1.5 increase but remain low and wane within 3 months back to pre-boost levels. These data suggest that once a year boosters with the current mRNA vaccines may not provide adequate protection for a
